HIPRADOG DHLP

Live vaccine,
canine parvovirus infections,
distemper, hepatitis and laryngotracheitis,
in injectable freeze-dried tablet,
and inactivated vaccine,
canine leptospirosis,
in injectable suspension

COMPOSITION:
PER DOSE (1 ML):
Freeze-dried fraction: Live canine parvovirus (CPV) C-780916 strain ≥ 106 TCID50; Live canine distemper virus (CDV) Lederle strain ≥ 104 TCID50; Live canine adenovirus type 2 (CAV2) Manhattan strain ≥ 104 DICT50.
Liquid fraction: Inactivated Leptospira icterohaemorrhagiae and Leptospira canicola ≥ 109microorganisms of each valence.

INDICATIONS:
Dogs: To prevent parvovirus infections, distemper, hepatitis, laryngotracheitis and leptospirosis.

SIDE EFFECTS:
• A sporadic anaphylactic reaction may appear in some sensitive animals. In such a case administer the appropriate symptomatic treatment.

ADMINISTRATION ROUTE:
Subcutaneous.

DOSAGE:
Dogs: 1 ml/dog, for all weights, ages, sex and breeds.
• Using a syringe, inject the liquid fraction into the vial that contains the freeze-dried fraction. Make sure that the vaccine is completely reconstituted before administering it.
• It is advisable to administer the first vaccination at 8 weeks of age and revaccinate at 12 weeks of age.
• It is recommended to administer an annual booster vaccination.

OBSERVATIONS:
• The vaccine should not be administered to animals with possible intestinal parasites, under stress or that are incubating an infectious or contagious disease.
• The innocuousness of this vaccine in gestating females has not been proved. Therefore, its use is not recommended in those animals.

SPECIAL PRECAUTIONS:
• Use the vaccine immediately after being reconstituted.
• Store at +2 to +8 ºC, protected from light. Do not freeze.

PACKAGING:
10 ds pack (freeze-dried fraction + liquid fraction).